Amsterdam, NL – It is projected that up to 152 million people worldwide will be living with Alzheimer’s disease (AD) by 2050. To date there are no drugs that...
Nantes, France – The lockdown, as implemented to cope with the COVID-19 pandemic, has drastically changed our everyday lives. Patients with Alzheimer’s disease...
Montreal, QC, Canada – A large-scale population-based study led by Paul Brassard, MD, of the Lady Davis Institute at the Jewish General Hospital, discovered...
Amsterdam, NL – The clinical presentation and underlying biology of Parkinson’s disease (PD) varies significantly, but attempts to cluster cases into a limited...
Amsterdam, NL – Parkinson’s disease (PD) is characterized by slowness of movement and tremors, which often appear asymmetrically in patients. The new model of...
Miami, FL, USA – A new University of Miami Miller School of Medicine-led study examined the relationship of neighborhood greenness, such as trees, shrubs, or...
Gainesville, FL, USA – A new University of Florida study of non-Hispanic Black and non-Hispanic white adults links, published in the Journal of Alzheimer's...
Amsterdam, NL – Individuals with Parkinson’s disease (PD) face a wide range of symptoms and challenges. A team from Parkinson’s UK, including several Patient...
Amsterdam, NL – The rarity of spinal muscular atrophy (SMA) means that promising new treatments may be tested in only a limited spectrum of patients before...
New York, NY, USA – Early in the pandemic, neurologists expressed concern that COVID-19 patients with dementia may be at higher risk for complications and...
London, UK – A large proportion of dementia deaths in England and Wales may be due to socioeconomic deprivation, according to new research led by Queen Mary...
